Global Overactive Bladder Therapeutics Market 2014-2018

Price :
Published : Nov-2014
No. of Pages : 91

Overactive bladder is a urological condition associated with urination problems. The condition is characterized by bladder storage symptoms such as urgency, change in frequency of urination, nocturia, or urinary incontinence. It is also known as overactive bladder syndrome. Although it is not a life-threatening condition, it is often stigmatized and debilitating. Some of the important symptoms of overactive bladder are urinary urgency and incontinence. The pathophysiology of overactive bladder is not characterized completely. The symptoms of overactive bladder can last for a lifetime or it can relapse and remit. The problem can be resolved through treatment. Overactive bladder can affect a person irrespective of the gender. The reason is the abnormal contraction of the urinary detrusor muscle of the bladder. In addition, overactive bladder can be related to neurological diseases such as Parkinson’s disease and multiple sclerosis.

TechNavio’s analysts forecast the Global Overactive Bladder Therapeutics market to grow at a CAGR of 1.14 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Overactive Bladder Therapeutics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of overactive bladder, which include:

  • Anti-muscarinic Agent
  • Beta-3-Adrenergic Receptor Agonist

TechNavio’s report, Global Overactive Bladder Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Overactive Bladder Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Actavis
  • Allergan
  • Astellas Pharma
  • Pfizer

Other Prominent Vendors

  • Addex Therapeutics
  • AltheRx Pharmaceuticals
  • American Oriental Bioengineering
  • Antares Pharma
  • Apogepha Arzneimittel
  • Auxilium Pharmaceuticals
  • Bayer
  • elbion
  • FemmePharma
  • Ferring Pharmaceuticals
  • GlaxoSmithKline
  • Hisamitsu Pharmaceutical
  • Hydra Biosciences
  • Ion Channel Innovations
  • Ipsen
  • Janssen
  • Kissei Pharma
  • Kwang Dong Pharmaceutical
  • KYORIN Pharma
  • Laboratorios SALVAT
  • LG Life Sciences
  • Lipella Pharmaceuticals
  • Merck
  • Motif BioSciences
  • Mylan
  • Novartis
  • Ono Pharmaceuticals
  • Ranbaxy Laboratories
  • Recordati
  • Sanofi
  • Sunovion
  • Takeda Pharmaceutical
  • TARIS BioMedical
  • Teva Pharmaceutical
  • TheraVida
  • Toray Industries
  • Urigen Pharmaceuticals

Market Driver

  • Rise in Geriatric Population
  • For a full, detailed list, view our report

Market Challenge

  • Difficulty in Disease Diagnosis
  • For a full, detailed list, view our report

Market Trend

  • Increase in Awareness
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Neurocrine Biosciences Inc (NBIX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamine transporter 2 inhibitor for the treatment of adults with tardive dyskinesia (TD). Its other major pipeline products include elagolix, a gonadotropin-releasing hormone (GnRH) antagonist for the treatment of endometriosis and uterine fibroids and opicapone, a catechol-O-methyltransferase inhibitor (COMT inhibitor) intended for adult patients with Parkinson's disease. It also develops drug candidates for the treatment of essential tremor and classic congenital adrenal hyperplasia. The company ha......

Exelixis Inc (EXEL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Exelixis Inc (Exelixis) is a biopharmaceutical company focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabometyx (cabozantinib) developed for the treatment of patients with advanced renal cell carcinoma; and Cotellic (cobimetinib) is developed in combination with vemurafenib for the treatment of patients with mutation-positive advanced melanoma. The company also enters into collaborative partnerships with pharmaceutical and biopharmaceutical companies to advance the development of potential therapies for cancer and other serious diseases. Exelixis is headquartered in South San Francisco, California, the US......

Express Scripts Holding Co (ESRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and medical and drug data analysis services. It also distributes a wide range of biopharmaceutical products and prescription drugs for specialty and orphan diseases; and provides cost-management and patient-care services. Express Scripts caters its services to clinics, managed care organizations, providers, hospitals, employers, union-sponsored benefit plans, health insurers, third-party administrators, workers' compensation plans and government health programs. Express Scripts is headquartered in S......

Chugai Pharmaceutical Co Ltd (4519) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Chugai Pharmaceutical Co Ltd (Chugai), a subsidiary of Hoffmann-La Roche Ltd, is a provider of biopharmaceuticals and therapeutic antibodies. The company offers products for the treatment of cancer; bone and joint diseases; renal diseases; immunology and infectious diseases and others. It also offers drugs to aid kidney, liver and other organ transplantations. Chugai's major products include Avastin (bevacizumab), Herceptin (trastuzumab), Rituxan (rituximab), Actemra (tocilizumab), Edirol (eldecalcitol) and Mircera (epoetin beta pegol). It also has a range of product candidates in its pipeline. The company offers its pharmaceutical products in overseas markets including North America, Europe and Asia. Chugai is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co Ltd (4519) - ......

BASF SE (BAS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, electronic chemicals, concrete admixtures, pigments, paints, food additives, fungicides, and herbicides. BASF also focuses on exploration and production in oil and gas-rich regions in Europe, North Africa, Russia, South America and the Middle East. The company caters to a wide range of industries including construction, furniture and wood, agriculture, paper and pulp, electronics and electrical, paints and coatings, automotive, home care, nutrition, chemicals and others. BASF carries out R&D in ......

DaVita Inc (DVA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). It also focuses on providing integrated health care delivery and management services. It also offers ancillary services, including pharmacy services such as DaVita Rx; infusion therapy services, disease management services; vascular access services; ESRD clinical research programs and physician services. The company operates through a network of outpatient dialysis centers in hospitals and related laboratory services. DaVita Medical Group manages and operates medical groups and affiliated phys......

Heidelberg Pharma AG (WL6) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Heidelberg Pharma AG(Heidelberg Pharma) formerly known as Wilex AG is a biopharmaceutical company with a focus on cancer. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. It develops products based on and small molecules and antibodies, which are offered for out-licensing. Wilex's pipeline products are focused at treating multiple myeloma, prostate cancer, hematological cancers, metastatic pancreatic cancers, leukemia, non- metastatic ccRCC, kidney cancers and solid tumors. Heidelberg Pharma GmbH (Heidelberg), Wilex's subsidiary provides preclinical contract research services and an antibody drug conjugate (ADC) technology platform. Heidelberg focuses on the development of a proprietary ADC technology. ......

Taiho Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group focuses on the development, production and marketing of pharmaceutical products in the fields of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic agents, anti-tumor agents, H2 receptor antagonists, antibiotics and medical devices; and consumer health products such as vitamin tonic, herbal digestive medicine, topical analgesics, antifungal cream, herbal medicine powder, and others. Taiho has production facilities in Tokushima, Saitama, Okayama, Kitajima and Inuyama. It operates through its subsidiaries in Japan, China, Singapore, the UK and the US. Taiho is headquartered in Tokyo, Japan. Taiho Pharmaceutical Co Ltd - Pharmaceuticals & Healt......

Evotec AG (EVT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory diseases. Evotec provides services such as integrated services, assay development and screening, reagent production services, ADMET, cellular target profiling, vitro pharmacology services and proteomics services. The company has long-term discovery alliances with several leading pharmaceutical companies and also has development partnerships for product candidates in clinical and pre-clinical development stages. The company has operating facilities in Abingdon and Manchester, the UK; Gottingen and M......

Weifa ASA (WEIFA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering products for pain relief; treatment of cough and colds; dermatology; Nutraceuticals; dietary supplements; and wound treatment among others. Its research and development activities focus on prescription drug products, OTC products and nutraceuticals. It offers products to consumers, customers and professional partners. The company has operational presence in Denmark, Iceland, Sweden and Finland. Weifa is headquartered in Oslo, Norway. Weifa ASA (WEIFA) - Pharmaceuticals & Healthcare - Deals and ......